http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#Head http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#assertion http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#provenance http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#pubinfo http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#assertion http://purl.obolibrary.org/obo/DOID_10283 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_10283 http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01248 http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#association http://www.w3.org/2000/01/rdf-schema#label docetaxel injection is a microtubule inhibitor indicated for breast cancer bc single agent for locally advanced or metastatic bc after chemotherapy failure and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node positive bc 1 1 non small cell lung cancer nsclc single agent for locally advanced or metastatic nsclc after platinum therapy failure and with cisplatin for unresectable locally advanced or metastatic untreated nsclc 1 2 hormone refractory prostate cancer hrpc with prednisone in androgen independent hormone refractory metastatic prostate cancer 1 3 gastric adenocarcinoma gc with cisplatin and fluorouracil for untreated advanced gc including the gastroesophageal junction 1 4 squamous cell carcinoma of the head and neck cancer scchn with cisplatin and fluorouracil for induction treatment of locally advanced scchn 1 5 docetaxel injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy docetaxel injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node positive breast cancer docetaxel injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non small cell lung cancer after failure of prior platinum based chemotherapy docetaxel injection in combination with cisplatin is indicated for the treatment of patients with unresectable locally advanced or metastatic non small cell lung cancer who have not previously received chemotherapy for this condition docetaxel injection in combination with prednisone is indicated for the treatment of patients with androgen independent hormone refractory metastatic prostate cancer docetaxel injection in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced gastric adenocarcinoma including adenocarcinoma of the gastroesophageal junction who have not received prior chemotherapy for advanced disease docetaxel injection in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck scchn http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01248 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#provenance http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#pubinfo http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#sig http://purl.org/nanopub/x/hasSignature Gqh0lXcBuNTl6f2x2vbFJ3Xe3nQouXL2o8bGnOAX85eDp8rX+BI38H2BNTg/hmlJWrcXNdCYqAiMQvY7bJSeen/x+TJe2pW2A+VCm0TekOo1m3UHZwzwVPeBn0nem5TxeLD4mCNKxGmH0nU4m8N5BGKl7Fg092AoPHmhX+G3dTk= http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ http://purl.org/dc/terms/created 2021-06-27T21:27:32.588+02:00 http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAv_btA50-cA8NlI336jHBzHi0U_oDol4v2ELJmTpeWCQ https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs